Physician

Michelle Liang, M.D.

According to 2025 Medicare claims, Michelle Liang, M.D. (NPI: 1437483310) practices ophthalmology in the Cambridge-Newton-Framingham, MA market, with the plurality of this provider's patient population coming from Essex, MA. This provider's primary affiliated billing organization is EYE CENTER OF THE NORTH SHORE, LLC (NPI: 1053562330; TIN: 263322759) and primary practice location at 01970-1783. Liang is affiliated with the Lahey Clinical Performance ACO (ACO ID: A1490), Mass General Brigham ACO, LLC (ACO ID: A4641), and Wellforce ACO, LLC (ACO ID: A4922), participating under the MSSP model.

Liang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,154 traditional Medicare patients, billed 39,362 HCPCS/CPT codes, and received $2,163,656 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 249 prescription claims across 74 beneficiaries totaling $32,759 in drug costs, led by Ilevro (Nepafenac). Open Payments data shows 26 records totaling $836. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $146,686 to $2,163,656. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,041 and ending at $32,759. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	416	1,268	$146,686
2016	715	4,457	$662,504
2017	879	5,441	$981,886
2018	1,078	7,693	$1,576,986
2019	1,228	8,878	$1,935,922
2020	1,139	7,922	$1,829,006
2021	1,279	9,573	$2,353,247
2022	1,216	11,518	$2,323,265
2023	1,157	31,285	$2,159,761
2024	1,154	39,362	$2,163,656

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	40	85	$5,041
2016	26	87	$10,879
2017	57	167	$56,668
2018	80	254	$52,664
2019	79	215	$30,601
2020	80	268	$47,077
2021	84	325	$57,130
2022	75	260	$39,567
2023	68	224	$35,239
2024	74	249	$32,759

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	179	1,071	$652
67028	Injection of drug into eye	353	1,261	$93
92014	Established patient complete exam of visual system	1,000	1,250	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	233	330	$66
92134	Imaging of retina	1,085	2,434	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ilevro	Nepafenac	14	629	$10,858
Bromfenac Sodium	Bromfenac Sodium	32	1,223	$6,774
Difluprednate	Difluprednate	27	1,540	$2,798
Prednisolone Acetate	Prednisolone Acetate	35	1,874	$2,364
Ketorolac Tromethamine	Ketorolac Tromethamine	54	2,510	$1,455

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$836	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michelle Liang, M.D.?

Tedicare shows public-source Medicare data for Michelle Liang, M.D. (NPI 1437483310), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michelle Liang, M.D. have ACO affiliation data?

Michelle Liang, M.D. is shown with ACO affiliation data for Lahey Clinical Performance ACO (MSSP, ACO ID A1490), Mass General Brigham ACO, LLC (MSSP, ACO ID A4641), and Wellforce ACO, LLC (MSSP, ACO ID A4922).

What billing organization is linked to Michelle Liang, M.D.?

Michelle Liang, M.D. is linked to EYE CENTER OF THE NORTH SHORE, LLC (billing NPI 1053562330) in the available physician profile data.

Does Michelle Liang, M.D. have Open Payments data?

Michelle Liang, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.